Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply

Andrew N.J. Tutt; Judy E. Garber; Charles E. Geyer

doi:10.1056/NEJMc2112373

Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply

Andrew N.J. Tutt, Judy E. Garber, Charles E. Geyer

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1440
Number of pages	1
Journal	The New England journal of medicine
Volume	385
Issue number	15
DOIs	https://doi.org/10.1056/NEJMc2112373
State	Published - Oct 7 2021

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1056/NEJMc2112373

Cite this

@article{567b43072325413ea192d549ccd3ab69,

title = "Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply",

author = "Tutt, {Andrew N.J.} and Garber, {Judy E.} and Geyer, {Charles E.}",

note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",

year = "2021",

month = oct,

day = "7",

doi = "10.1056/NEJMc2112373",

language = "English (US)",

volume = "385",

pages = "1440",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply

AU - Tutt, Andrew N.J.

AU - Garber, Judy E.

AU - Geyer, Charles E.

N1 - Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

PY - 2021/10/7

Y1 - 2021/10/7

UR - http://www.scopus.com/inward/record.url?scp=85117807331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117807331&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2112373

DO - 10.1056/NEJMc2112373

M3 - Letter

C2 - 34614338

AN - SCOPUS:85117807331

VL - 385

SP - 1440

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 15

ER -

Adjuvant Olaparib in BRCA-Mutated Breast Cancer. Reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this